For $1,200, anyone can publish junk science

Candace Stuart | | Cardiovascular Business | Patient Care

The title “VEGF proliferation in cardiac cells contributes to vascular declension” may sound like rubbish to any cardiologist, but to the publishers who bought the once reputable Experimental and Clinical Cardiology journal, it means cha-ching. In an investigation on predatory publishers, the Ottawa Citizen saw its spoof submission make print in the journal after paying $1,200. 

Respected medical journal turns to the dark side

Candace Stuart, Contributor

Related Content

Concomitant ablation surgery during heart operations boosts long-term survival
Cardiologist explores why colchicine failed to help heart attack patients
Bioresorbable BTK stent superior to ballon angioplasty at 2 years
Most heart failure patients miss out on guideline-recommended palliative care
Cardiologist behind EARLY TAVR explains how proactive treatment improves patient outcomes
FDA approves Medtronic’s new all-in-one mapping and ablation system for AFib

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."